March & April 2024 PubMed Articles

The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the Foundation.

Below are the top articles for March and April 2024:

March 2024

Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease

    • Rohit Loomba
    • Ginger Clark
    • Jeff Teckman
    • Mark Brantly 
    • Jeanine D’Armiento
    • Alice Turner 
    • Pavel Strnad

    Improving the diagnosis of AATD with aid of serum protein electrophoresis: a prospective, multicentre, validation study

    • Ilaria Ferrarotti

    Computational Tools to Assist in Analyzing Effects of the SERPINA1 Gene Variation on Alpha-1 Antitrypsin (AAT)

    • Joanna Chorostowska-Wynimko

    Biodistribution and safety of a single rAAV3B-AAT vector for silencing and replacement of alpha-1 antitrypsin in Cynomolgus macaques

      • Christian Mueller 
      • Terence R. Flotte

      Characteristics associated with SF-36 in alpha-1 antitrypsin deficiency-associated COPD: a cross-sectional analysis

        • Robert A. Sandhaus
        • Charlie Strange 

        Cardiovascular disease in Alpha 1 antitrypsin deficiency: an observational study assessing the role of neutrophil proteinase activity and the suitability of validated screening tools

        • Robert Stockley

        April 2024

        Alpha-1 Antitrypsin Deficiency

        • Francisco Dasi

        Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression

        • Pavel Strnad

        Genetic epidemiology of alpha-1 antitrypsin deficiency in Macaronesia

        • Marc Miravitlles

        Long-Term SGRQ Stability in a Cohort of Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

        • Robert A. Sandhaus
        • Charlie Strange

        Efficacy and safety of the Spiration Valve System™ for the treatment of severe emphysema in patients with Alpha-1 antitrypsin deficiency (EMPROVE)

        • Kyle Hogarth

        Reply to Chan: Identification of Alpha-1 Antitrypsin-Deficient Subjects with Normal Spirometry Who May Benefit from Alpha-1 Antitrypsin Replacement

        • Auyon J. Gosh
        • Tomas Carroll
        • Gerry McElvaney

        Leave a Reply

        Your email address will not be published. Required fields are marked *